Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-12-12
2006-12-12
Duffy, Patricia A. (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007200, C435S007320, C435S188500, C436S518000, C436S519000
Reexamination Certificate
active
07148028
ABSTRACT:
The present invention relates to the identification of lipid oxidising antibodies as a key pathogenic factor in atherosclerotic disorders. The presence of such antibodies is a important marker for the diagnosis and prognosis of such disorders and methods and means for the assessment of athersclerotic conditions are provided herein.
REFERENCES:
patent: 5278189 (1994-01-01), Rath et al.
patent: 6281199 (2001-08-01), Gupta
patent: 0561744 (1993-09-01), None
patent: 0669132 (1995-08-01), None
patent: 92/05780 (1992-04-01), None
patent: 97/41227 (1997-11-01), None
patent: 98/57622 (1998-12-01), None
patent: 01/22958 (2001-04-01), None
Saikku et al, Annals of Internal Medicine, 116(4):273-278, 1992).
Shoenfeld et al (Trends in Immunology, 22(6):293-295, Jun. 2001).
Kelley et al, (Environmental Health Perspectives, 106(7):375-384, Jul. 1998).
ICN product catalog 92/93.
Roitt et al., Immunology, Third Edition, Mosby 1993. pp. 4.1-4.3).
Schwenke et al, Vitamin E. Combined With Selenium Inhibits Atherosclerosis in Hypercholesterolemic Rabbits Independently of Effects on Plasma Cholesterol Concentrations, Circ. Res., Aug. 24, 1998, vol. 83, pp. 366-377.
Fong et al, Can an Antibiotic (Macrolide) PreventChlamydia pneumoniae-Induced Atherosclerosis in a Rabbit Model? Clinical and Diagnostic Laboratory Immunology, Nov. 1999, vol. 6, No. 6, pp. 891-894.
Muhlestein et al, Infection WithChlamydia pneumonaieAccelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model, Circulation, vol. 97, pp. 633-636.
Petyaev, Extraction of anti-lipoprotein abzymes from human atherosclerotic lesion: antibodies which bind and oxidise LDL, J Submicroscop Cytol Pathol; vol. 32, pp. 477 (2000).
Kalayoglu et al, Cellular Oxidation of Low-Density Lipoprotein byChlamydia pneumoniae, J Infect Disease, 1999, vol. 180, pp. 780-790.
Burian et al, Independent and Joint Effects of Antibodies to Human Heat-Shock Protein 60 andChlamydia pneumoniaeinfection in the Development of Coronary Atherosclerosis, Circulation, 2001, vol. 103, pp. 1503-1508.
Petyaev et al, Superoxide Dismutase Activity of Antibodies Purified from the Human Arteries and Athersclerotic Lesions, Biochemical Society Transactions, Feb. 1998, vol. 26, No. 1, p. S43.
Sobal et al, Influence of Acetylsalicylic Acid on Oxidation of Native and Glycated Low-Density Lipoprotein, Life Sciences, Apr. 7, 2000, vol. 66, No. 20, pp. 1987-1998.
Steer et al, Aspirin protects low density lipoprotein from oxidative modification, Heart, 1997, vol. 77 No. 4, pp. 333-337.
Gurfinkel et al, Emerging role of antibiotics in atherosclerosis, American Heart Journal, Nov. 1999, vol. 138, No. 5, pp. S537-538.
Imanishi et al, Jpn Circ. J., 2001, vol. 65, No. 6, pp. 556-560.
Kolodgie et al, Cardiovascular Disease, Feb. 2001, vol. 19, No. 1, pp. 127-139.
Rodriguez-Malaver et al, FEBS Letters, 1997, vol. 406, pp. 37-41.
Turley et al, Free Radical Biology & Medicine, 2000, vol. 29, No. 11, pp. 1129-1134.
Wilkins et al, Biochimica et Biophysica Acta, 1994, vol. 1215, pp. 250-258.
Lamb et al, FEBS Letters, 1994, vol. 352, pp. 15-18.
Cambridge Theranostics Ltd.
Duffy Patricia A.
Nixon & Vanderhye P.C.
LandOfFree
Methods and means relating to atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and means relating to atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and means relating to atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3711133